Dou Yanna, Wang Pei, Yuan Fangfang, Liang Xianhui, Liu Dong, Xiao Jing, Zhao Zhanzheng, Liu Zhangsuo
The Nephrology Center of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhengzhou University Institute of Nephrology, Zhengzhou, China.
Asia Pac J Clin Nutr. 2017 Jan;26(1):6-10. doi: 10.6133/apjcn.122015.03.
The aim of the present study was to retrospectively analyze the relationship between the Geriatric Nutritional Risk Index (GNRI) at baseline and healthcare costs of three-month as well as the risk of quality-of-life score at the 6-month follow-up for Chinese hemodialysis patients.
One hundred patients who had been on maintenance hemodialysis were enrolled in this study. The general characteristics, laboratory test results and GNRI of the patients at baseline were recorded. The healthcare costs and quality-of-life scores were determined at the follow-up examination.
Patients were divided into two groups according to their median GNRI at baseline: a lower GNRI group (GNRI <86.4) and a higher GNRI group (GNRI >86.4). The patients in the lower GNRI group exhibited reduced hemoglobin (74.7±13.1 g/dL vs 82.3±15.2 g/dL, p<0.05) and albumin (27.4±3.3 g/L vs 34.5±4.0 g/L, p<0.05) as well as reduced body weight (62.7±9.5 kg vs 68.0±9.2 kg, p<0.05) at baseline. The medication cost at follow-up was higher in the lower GNRI group (RMB 3,238±1,534 vs RMB 2,378±1,048, p<0.05). And a lower GNRI at baseline was associated with increased future medication costs and worse health in hemodialysis patients.
The present study suggests that a lower GNRI in hemodialysis patients may be associated with an increased risk of higher future healthcare costs as well as worse health.
本研究旨在回顾性分析中国血液透析患者基线时的老年营养风险指数(GNRI)与三个月医疗费用以及6个月随访时生活质量评分风险之间的关系。
本研究纳入了100例维持性血液透析患者。记录患者基线时的一般特征、实验室检查结果和GNRI。在随访检查时确定医疗费用和生活质量评分。
根据患者基线时的GNRI中位数将患者分为两组:低GNRI组(GNRI<86.4)和高GNRI组(GNRI>86.4)。低GNRI组患者在基线时血红蛋白降低(74.7±13.1 g/dL对82.3±15.2 g/dL,p<0.05)、白蛋白降低(27.4±3.3 g/L对34.5±4.0 g/L,p<0.05)以及体重降低(62.7±9.5 kg对68.0±9.2 kg,p<0.05)。随访时低GNRI组的药物费用更高(3238±1534元对2378±1048元,p<0.05)。基线时较低的GNRI与血液透析患者未来更高的药物费用和更差的健康状况相关。
本研究表明,血液透析患者较低的GNRI可能与未来更高的医疗费用风险增加以及更差的健康状况相关。